Amgen Gets Mixed Ruling In Patent Fight
The U.S. Court of Appeals for the Federal Circuit Thursday issued a mixed ruling in Amgen Inc.'s nearly decade-long legal spat with two pharmaceutical companies over patents related to Amgen's blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article